Adjunctive Pharmacology for Coronary Intervention

作者: Osman Faheem , John K. Forrest

DOI: 10.1007/978-1-4471-4528-8_11

关键词:

摘要: Platelets play a pivotal role in the development of arterial thrombus formation both setting plaque rupture during ST elevation myocardial infarction (STEMI) and routine PCI through disruption previously stable coronary plaques. In acute syndromes, there are critical changes that occur within platelets promote clot formation. These include (1) platelet adhesion mediated by von Willebrand factor other adhesive proteins; (2) activation, part thromboxane A2; (3) aggregation due to fibrinogen cross-linking (Fig. 11.1). Many commonly used oral antiplatelet agents discussed subsequently work mechanisms disrupt one or more these pathways.

参考文章(117)
George D Dangas, Roxana Mehran, Eugenia Nikolsky, Bimmer E Claessen, Alexandra J Lansky, Bruce R Brodie, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z Peruga, Dariusz Dudek, Martin Möckel, Adriano Caixeta, Helen Parise, Harvey White, Gregg W Stone, HORIZONS-AMI Trial Investigators, Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction: The HORIZONS-SWITCH Analysis Journal of the American College of Cardiology. ,vol. 57, pp. 2309- 2316 ,(2011) , 10.1016/J.JACC.2011.01.038
Salim Yusuf, Shamir R Mehta, Susan Chrolavicius, Janine Pogue, Christopher B Granger, Andrzej Budaj, Ron JG Peters, Jean-Pierre Bassand, Lars Wallentin, Campbell Joyner, Keith AA Fox, None, Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial JAMA. ,vol. 295, pp. 1519- 1530 ,(2006) , 10.1001/JAMA.295.13.JOC60038
Thaddeus R Tolleson, J.Conor O’Shea, John A Bittl, William B Hillegass, Kathryn A Williams, Glenn Levine, Robert A Harrington, James E Tcheng, Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial Journal of the American College of Cardiology. ,vol. 41, pp. 386- 393 ,(2003) , 10.1016/S0735-1097(02)02767-5
Karl-Ludwig Neuhaus, G.Peter Molhoek, Uwe Zeymer, Ulrich Tebbe, Karl Wegscheider, Rolf Schröder, Anne Camez, G.Jan Laarman, Gilles M Grollier, Dirk J.A Lok, Holger Kuckuck, Peter Lazarus, Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial. Journal of the American College of Cardiology. ,vol. 34, pp. 966- 973 ,(1999) , 10.1016/S0735-1097(99)00319-8
Bernd Pötzsch, Katharina Madlener, Christoph Seelig, Christian F Riess, Andreas Greinacher, Gert Müller-Berghaus, Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time. Thrombosis and Haemostasis. ,vol. 77, pp. 920- 925 ,(1997) , 10.1055/S-0038-1656078
Eugenio Stabile, Wail Nammas, Luigi Salemme, Giovanni Sorropago, Angelo Cioppa, Tullio Tesorio, Vittorio Ambrosini, Esther Campopiano, Gregory Popusoi, Giuseppe Biondi Zoccai, Paolo Rubino, The CIAO (Coronary Interventions Antiplatelet-based Only) Study Journal of the American College of Cardiology. ,vol. 52, pp. 1293- 1298 ,(2008) , 10.1016/J.JACC.2008.07.026
Ganesan Karthikeyan, John W. Eikelboom, Apixaban in acute coronary syndromes. Cardiovascular Therapeutics. ,vol. 29, pp. 285- 290 ,(2011) , 10.1111/J.1755-5922.2010.00195.X
John Posner, Optimizing the dose of dabigatran etexilate. British Journal of Clinical Pharmacology. ,vol. 74, pp. 741- 743 ,(2012) , 10.1111/J.1365-2125.2012.04353.X
Frank Vermeer, Alec Vahanian, Phonse W Fels, Pierre Besse, Evert Müller, Frans Van de Werf, Detmond Fitzgerald, Harald Darius, Jean Puel, Desirée Garrigou, Maarten L Simoons, Argatroban and alteplase in patients with acute myocardial infarction: the ARGAMI Study. Journal of Thrombosis and Thrombolysis. ,vol. 10, pp. 233- 240 ,(2000) , 10.1023/A:1026591023462